Dr. Kurtulus Gokduman received his B.Sc. degree in Biology, M.Sc. degree in Biotechnology, and Ph.D. degree in Biotechnology from Middle East Technical University, Ankara, Turkey. During his Ph.D. studies, he focused on the development of molecular genetic tools for Salmonella detection, as well as on the development of targeted and sustained delivery of Camptothecin anticancer drugs in bioactive form using iron oxide micro and nanoparticles. These researches have led to several publications and national/international patent applications.
He performed post-doctoral research at Harvard Medical School, Harvard University, Boston, MA-USA, on the investigation of hepatotoxicity profiles of superparamagnetic iron oxide nanoparticles using primary hepatocyte models in static conditions as well as in dynamic liver-on-a-chip platforms.
Currently, his researches focus on micro/nano-systems for biomedical applications, involving tumor/organ-on-a-chip, in vitro diagnostic, nanotheranostic, nanomolecular medicine and nanotoxicology studies.
•Ph.D. in Biotechnology, Middle East Technical University, Ankara-TURKEY (2012)
•M.Sc. in Biotechnology, Middle East Technical University, Ankara-TURKEY (2005)
•B.Sc. in Biology, Middle East Technical University, Ankara-TURKEY (2003)
Micro-Systems for Biomedical Applications
•Development of tumor-on-a-chip platforms to test the efficacy of the drugs or nano delivery systems for the drugs
•Development of organ-on-a-chip platforms to test the side effects of the drugs or nano delivery systems for the drugs
•Development of microfluidic systems for diagnostic applications
Nano-Systems for Biomedical Applications
•Nanotheranostic studies to develop nano-systems allowing simultaneous diagnostic imaging and therapy
•Nanomolecular medicine studies to investigate biological interactions of nanomaterials
•Nanotoxicology studies to investigate toxicological profiles of nanomaterials
•Current Drug Targets
•Anti-Cancer Agents in Medicinal Chemistry
•Nanomaterials and Nanotechnology